You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1b/2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

Not yet recruiting
  • Pulmonary Sarcoidosis
  • XTMAB-16 or Placebo
  • (no location specified)
May 25, 2023

Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 27, 2023

Metastatic Breast Cancer Trial in Pompano Beach, Caracas (ConvitVax)

Not yet recruiting
  • Metastatic Breast Cancer
  • ConvitVax
  • Pompano Beach, Florida
  • +2 more
Aug 28, 2023

Cholangiocarcinoma Trial (GNS561 + Trametinib)

Not yet recruiting
  • Cholangiocarcinoma
  • GNS561 + Trametinib
  • (no location specified)
May 22, 2023

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)

Not yet recruiting
  • Leprosy
  • LEP-F1 + GLA-SE
  • Placebo
  • Rio de Janeiro, Brazil
    Veronica Schmitz Pereira
Dec 5, 2022

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • toripalimab FOLFOX
  • (no location specified)
Aug 3, 2023

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Spinal Cord Injuries, Chronic Spinal Cord Injury, Subacute Spinal Cord Injury Trial in Chicago (NVG-291)

Not yet recruiting
  • Spinal Cord Injuries
  • +2 more
  • Chicago, Illinois
  • +1 more
Jul 31, 2023

Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)

Not yet recruiting
  • Myasthenia Gravis
  • +3 more
  • Chicago, Illinois
    Research Site
Oct 30, 2023

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Advanced Solid Tumours Trial in Belgium, France (EXS21546)

Recruiting
  • Advanced Solid Tumours
  • Brussels, Belgium
  • +4 more
Jun 26, 2023

Hypertriglyceridemia Trial (MAR001, Placebo)

Not yet recruiting
  • Hypertriglyceridemia
  • (no location specified)
May 31, 2023

Long QT Syndrome Trial in West Bend (LQT-1213, Placebo, Dofetilide 250 µg Cap)

Active, not recruiting
  • Long QT Syndrome
  • West Bend, Wisconsin
    Spaulding Clinical Research, LLC
Jun 15, 2023

Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations, NSCLC, KRAS Gene Mutation Trial in Santa Monica,

Recruiting
  • Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations
  • +2 more
  • Futibatinib and Binimetinib
  • Santa Monica, California
  • +2 more
Jun 2, 2022

Advanced Pancreatic Carcinoma Trial in Miramar (HCW9218)

Not yet recruiting
  • Advanced Pancreatic Carcinoma
  • Miramar, Florida
    HCW Biologics
Aug 2, 2022

Primary Membranous Nephropathy Trial (EVER001)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Mar 23, 2023

Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)

Not yet recruiting
  • Recurrent or Metastatic Colorectal Cancer
  • Nelmastobart and Capecitabine
  • (no location specified)
Aug 6, 2023